Whole blood transfusions in 91 cats: A clinical evaluation

2004 ◽  
Vol 6 (3) ◽  
pp. 139-148 ◽  
Author(s):  
C. Weingart ◽  
U. Giger ◽  
B. Kohn
Keyword(s):  
Clinical Evaluation ◽  
Whole Blood ◽  
Blood Transfusions

Whole Blood Transfusions in Surgical Practice

1959 ◽  
Vol 39 (1) ◽  
pp. 121-131 ◽  
Author(s):  
Thomas W. Shields ◽  
Walter A. Rambach
Keyword(s):  
Whole Blood ◽  
Blood Transfusions ◽  
Surgical Practice

EFFECTS OF FRESH PLASMA OR WHOLE BLOOD TRANSFUSIONS ON PATIENTS WITH VARIOUS TYPES OF MUCOPOLYSACCHARIDOSIS

PEDIATRICS ◽  
1972 ◽  
Vol 50 (5) ◽  
pp. 688-692
Author(s):  
Anatole S. Dekaban ◽  
Kenton R. Holden ◽  
George Constantopoulos
Keyword(s):  
Molecular Weight ◽  
Weight Distribution ◽  
Whole Blood ◽  
Blood Transfusions ◽  
Molecular Weights ◽  
The Third ◽  
Clinical Observations ◽  
Before And After ◽  
Fresh Plasma

Repeated fresh plasma or whole blood transfusions were given to five patients with either Hurler, Hunter, or Sanfilippo types of mucopolysaccharidosis. Clinical observations and total 24-hour urinary AMPS and their composition and molecular weight distribution were determined before, during, and after transfusions. The two patients who received plasma transfusions showed no noticeable change in the amount of AMPS excreted; of the three patients who received whole blood transfusions, two had slightly less excretion of AMPS while the third showed no difference. The AMPS in the CSF were measured in one patient before and after blood transfusions and found to be unchanged; likewise, the determination of molecular weights in the isolated AMPS was virtually identical. In the patients studied, the transfusions caused no demonstrable difference in the patients' clinical condition.

Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.

1995 ◽  
Vol 13 (7) ◽  
pp. 1671-1678 ◽  
Author(s):  
J H Donohue ◽  
S Williams ◽  
S Cha ◽  
H E Windschitl ◽  
T E Witzig ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Colorectal Carcinoma ◽  
Whole Blood ◽  
Tumor Recurrence ◽  
Patient Survival ◽  
Tumor Stage ◽  
Disease Recurrence ◽  
Blood Transfusions ◽  
Blood Components ◽  
Cell Kinetic

PURPOSE To evaluate the effect of perioperative blood transfusions on colorectal cancer recurrence and patient survival. PATIENTS AND METHODS A total of 1,051 patients treated with curative surgery for stage II or III colorectal adenocarcinoma were retrospectively studied for the effect of perioperative blood transfusions on disease recurrence and patient survival. Forty-two percent of patients received perioperative blood components. RESULTS Perioperative transfusions had no effect on disease progression in univariate or multivariate analysis. Tumor stage (P = .0001), locally advanced tumor characteristics (adherence, involvement of adjacent structure, or perforation; P = .0001), location (rectal v colon; P = .0002), grade (P < .001), and cell kinetic profile (nondiploid or high percent synthetic phase [%S]+ percent gap 2 mitosis phase [%G2M]; P = .0003) were the most powerful independent predictors of tumor recurrence. Use of transfusions was associated with an adverse effect on overall survival (P < .004) using multivariate analysis, as well as tumor stage (P = .0001), location (P = .004), grade (P = .001), patient age (P = .0001), sex (P < .04), and cell kinetic profile (P = .0001). In further evaluation of the prognostic effects of transfusions, there was no increased risk of disease recurrence after whole-blood transfusion (P = .14) as compared with packed RBC or no transfusions, although the disease-specific survival for patients who received whole blood was lower than for nontransfused patients (P < .0005) patients who received other blood components (P < .03). CONCLUSION With transfusion practices that use blood components, most commonly RBCs, medically indicated transfusions to patients with colorectal carcinoma seem to have no impact on disease recurrence. The adverse impact of transfusions on cancer patient survival is more likely due to other unevaluated tumor variables or underlying illness rather than tumor recurrence enhancement by immunosuppression induced by transfusion of blood components.

scholarly journals Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Markandey M. Tripathi ◽  
Satoru Egawa ◽  
Alexandra G. Wirth ◽  
Diane M. Tshikudi ◽  
Elizabeth M. Van Cott ◽  
...  
Keyword(s):  
Prothrombin Time ◽  
Clinical Evaluation ◽  
Whole Blood ◽  
International Normalized Ratio ◽  
Laser Speckle

Clinical evaluation of a new fully automated enzyme immunoassay for basophil histamine release in whole blood

2000 ◽  
Vol 49 (S1) ◽  
pp. 49-50 ◽  
Author(s):  
T. M. Li ◽  
K. J. Kontis ◽  
F. Rance ◽  
M. Abbal ◽  
D. A. Vuitton
Keyword(s):  
Histamine Release ◽  
Enzyme Immunoassay ◽  
Clinical Evaluation ◽  
Whole Blood

WHOLE BLOOD TRANSFUSIONS

1955 ◽  
Vol 159 (15) ◽  
pp. 1480
Author(s):  
Malcolm A. Hyman
Keyword(s):  
Whole Blood ◽  
Blood Transfusions
Sign in / Sign up

Export Citation Format

Share Document